Deals

CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
EUR590.0005Nov-24Sr. UnsecuredA3A--FixedSwapsMS+60-65MS+40-45400.10%-99.64200
EUR590.0008Nov-27Sr. UnsecuredA3A--FixedSwapsMS+80 aMS+55 a520.38%-499.25600
Tranche Comments
5 yr: Book size: 1400; Registration: Reg S Only; Comments: EUR590m 5yr. With 8yr. RegS. A3/A-. Barc(B&D)/BofA/JPM/MS. IPTs MS+60/+65, guidance MS+40/45, set MS+40, bk ~1.4bn (peaked ~2.1bn), HR 98% vs OBL Oct 2024+75.6 @102.92. 1mPC. B+15 MWC. FTT 3.45pm. Tax Call: No. PP: No. XD: No; 8 yr: Book size: 1500; Registration: Reg S Only; Comments: EUR590m 8yr. With 5yr. RegS. A3/A-. Barc(B&D)/BofA/JPM/MS. IPTs MS+80 area, guidance MS+55 (+/-3), set MS+52, bk ~1.5bn (peaked ~3.25bn). HR 95% vs DBR Aug 2027+95 @107.75. MWC B+20, 3mPC. FTT 3.45pm. Tax Call: No. PP: No. XD: No;
Guarantor(s)
Abbott Laboratories
Use of Proceeds
Refinancing

B&I

BWICS & Inventory

Research

Explore all other research.